Section
Policy
IRA, state PBM reform, Medicare, and regulatory action
PolicyFiercePharma ↗
The Biotechnology Innovation Organization has started the nationwide “The Fight of Our Lives” campaign, creat…
PolicyBriefing
Viatris pulled one lot of extended-release Xanax, and Teva recalled multiple lots of clonidine patches over co…
PolicyFiercePharma ↗
The FDA has scolded Pfizer over Facebook ads for the cancer drug Adcetris, accusing the Big Pharma of failing …
PolicyFiercePharma ↗
The FDA should strengthen the evidence required for drug approvals under its accelerated pathway, and increase…
PolicyFiercePharma ↗
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansion…
PolicyFiercePharma ↗
The legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva gaining favor on…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.